AF recurrence (n= 10, 35.7%) No AF recurrence (n= 18, 64.3%)
P-Value
Demographics Demographics Demographics Demographics
Age (years) 54.3±12.4 60.3±10.3 0.16
Males (%) 6 (60%) 14 (77.8%) 0.53
BMI (Kg/m2) 29.2±4.4 29.9±6.1 0.74
AF type AF type AF type AF type
Paroxysmal (%) 3 (30) 9 (50) 0.28
Persistent (%) 6 (60) 9 (50)
Long-standing persistent (%) 1 (10) 0 (0)
Echocardiographic parameters Echocardiographic parameters Echocardiographic parameters Echocardiographic parameters
IVS thickness (mm) 16.3±1.8 15.5±2.0 0.40
LVEDD (mm) 45.4±6.2 46.7±5.1 0.61
LA diameter (mm) 48.4±3.7 46.5±4.5 0.33
LA volume (ml) 136.7±13.7 126.1±14.7 0.18
LVOT gradient (mmHg) 41.8±1.8 43.7±2.7 0.06
LVEF (%) 55±5.8 59.3±8.5 0.11
Medications Medications Medications Medications
Amiodarone (%) 9 (90) 11 (61.1) 0.19
Anticoagulation regimen Anticoagulation regimen Anticoagulation regimen Anticoagulation regimen
Dabigatran (%) 1 (10) 4 (22.2) 0.32
Apixaban (%) 4 (40) 3 (16.7)
Rivaroxaban (%) 2 (20) 8 (44.4)
Acenocoumarol (%) 3 (30) 3 (16.7)
Medical History Medical History Medical History Medical History
Stroke (%) 1 (10) 1 (5.6) 1.0
Hypertension (%) 3 (30) 12 (66.7) 0.11
Diabetes Mellitus (%) 1 (10) 2 (11.1) 1.0
Dyslipidemia (%) 2 (20) 8 (44.4) 0.25
Procedural data Procedural data Procedural data Procedural data
Complications (%) 0 (0) 0 (0) -
Procedure time (min) 139±99.1 114.7±92.9 0.36